Story
Samsung Biologics to Acquire PolyPeptide for $1.8 Billion in GLP-1 Market Push
Samsung Biologics Co Ltd (KS:207940) announced on Monday it will acquire Switzerland’s PolyPeptide Group AG (SIX:PPGN) in an all-cash transaction valued at approximately 1.46 billion Swiss francs ($1.8 billion). The move marks a significant strategic expansion for the South Korean contract drugmaker into the rapidly growing market for peptide-based therapies.
Deal Details
Under the terms of the agreement, Samsung Biologics will offer 44.31 Swiss francs per share. This represents a 6.1% premium to PolyPeptide's closing share price on the preceding Friday. The transaction is expected to close by the end of 2026, pending regulatory approvals and other standard closing conditions.
The deal has received strong backing from the Swiss firm. PolyPeptide's board of directors has unanimously recommended the offer, and shareholders representing about 55.65% of the company's shares have already committed to tender their holdings, according to the announcement.
Strategic Rationale
AdThe acquisition is designed to bolster Samsung Biologics' capabilities in producing peptide active pharmaceutical ingredients (APIs). The company specifically highlighted the rising global demand for GLP-1 agonists, a class of drugs widely used in popular obesity and metabolic disease treatments.
By acquiring PolyPeptide, Samsung Biologics will also gain a significant global manufacturing footprint. The deal includes PolyPeptide's facilities in Sweden, Belgium, France, the United States, and India, providing an immediate and geographically diverse expansion.
Market Reaction
Following the announcement, shares of Samsung Biologics fell 3.4% to 1,354,000 won in Seoul trading on Monday. However, the company's stock outperformed the broader South Korean market, as the KOSPI index dropped a steeper 4.1% during the same session.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.